559 related articles for article (PubMed ID: 21762203)
21. Effect of simultaneous and/or consecutive administration of the broad spectrum anthelmintic flubendazole together with praziquantel in experimental Schistosoma mansoni infection.
William S; Guirguis F; Nessim NG
Arzneimittelforschung; 2003; 53(7):532-7. PubMed ID: 12918221
[TBL] [Abstract][Full Text] [Related]
22. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
23. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
Mohamed AH; Osman GY; Salem TA; Elmalawany AM
Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189
[TBL] [Abstract][Full Text] [Related]
24. Parasitological and immunological changes in murine hepatic schistosomiasis before and after praziquantel treatment.
el-Shafei MM; Mattar MA; Afify HA
J Egypt Soc Parasitol; 2002 Aug; 32(2):551-60. PubMed ID: 12214932
[TBL] [Abstract][Full Text] [Related]
25. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
[TBL] [Abstract][Full Text] [Related]
26. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
27. Drug-metabolizing enzymes and praziquantel bioavailability in mice harboring Schistosoma mansoni isolates of different drug susceptibilities.
Botros SS; El-Din SH; El-Lakkany NM; Sabra AN; Ebeid FA
J Parasitol; 2006 Dec; 92(6):1344-9. PubMed ID: 17304818
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of a Brazilian wild rodent isolate of Schistosoma mansoni to praziquantel in mice.
Costa-Silva M; Barros Lde A; Garcia JS; Neves RH; Rodrigues-Silva R; Machado-Silva JR; Maldonado-Júnior A
Exp Parasitol; 2012 Apr; 130(4):394-9. PubMed ID: 22343042
[TBL] [Abstract][Full Text] [Related]
29. Effect of octreotide on the pathology of hepatic schistosomiasis.
Mansy SS; Yehia HA; Hassan MM; Hassan EA; Youssef MM; Hadi AA; Mackenzie CD
Arzneimittelforschung; 1998 Aug; 48(8):855-61. PubMed ID: 9748716
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and bioavailability of different praziquantel brands.
Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection.
Hassan SI; Ali I; Nessim NG; Amer NM; Abd el Kader el Khafif M; Ashour A; el Mohandes M
Arzneimittelforschung; 2003; 53(6):440-4. PubMed ID: 12872615
[TBL] [Abstract][Full Text] [Related]
33. Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Helmy MM; Mahmoud SS; Fahmy ZH
Exp Parasitol; 2009 Aug; 122(4):310-7. PubMed ID: 19389399
[TBL] [Abstract][Full Text] [Related]
34. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice.
Giboda M; Smith JM
J Trop Med Hyg; 1994 Apr; 97(2):98-102. PubMed ID: 8170010
[TBL] [Abstract][Full Text] [Related]
35. Schistosomicidal, antifibrotic and antioxidant effects of Cucurbita pepo L. seed oil and praziquantel combined treatment for Schistosoma mansoni infection in a mouse model.
Beshay EVN; Rady AA; Afifi AF; Mohamed AH
J Helminthol; 2019 May; 93(3):286-294. PubMed ID: 29655377
[TBL] [Abstract][Full Text] [Related]
36. Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; El-Karef AA; Abou-El-Wafa HS
Biomed Pharmacother; 2017 Nov; 95():1346-1358. PubMed ID: 28946182
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of antihelminthic compound; Clorsulon against experimental Schistosoma mansoni infection.
Mossallam SF; Ali SM; El Zawawy LA; Said DE
J Egypt Soc Parasitol; 2007 Apr; 37(1):171-88. PubMed ID: 17580576
[TBL] [Abstract][Full Text] [Related]
38. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
William S; Botros S
Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
[TBL] [Abstract][Full Text] [Related]
39. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
[TBL] [Abstract][Full Text] [Related]
40. Dandelion (Taraxacum officinale) Improves the Therapeutic Efficiency of Praziquantel in Experimental Schistosomiasis.
Atwa MTM; Abd-Elrazek AM; Salem NIS
Acta Parasitol; 2022 Jun; 67(2):773-783. PubMed ID: 35067863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
